Oncovalent Therapeutics Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Oncovalent Therapeutics is an early-stage biotechnology company focused on oncology therapeutics. It leverages expertise in medicinal chemistry and biology to advance selective small-molecule drug candidates that could deliver clinical benefits to cancer patients. The company concentrates on challenging, disease-relevant pathways and aims to translate scientific insights into therapies. The organization is based in Thousand Oaks, California, in the Newbury Park area. It operates with a relatively small team of researchers dedicated to oncology drug development. The oncology patient is at the center of its work, reflecting a focus on translating science into therapies for cancer.